Cellosaurus cell line CSQT-2 (CVCL

Cross-references
Cell line name	CSQT-2
Accession	CVCL_M183
Resource Identification Initiative	To cite this cell line use: CSQT-2 (RRID:CVCL_M183)
Comments	Group: Patented cell line. Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200913. Population: Chinese. Doubling time: 36 hours (Patent=CN101955914B). Derived from site: Metastatic; Portal vein; UBERON=UBERON_0002017.
Disease	Adult hepatocellular carcinoma (NCIt: C7956) Adult hepatocellular carcinoma (ORDO: Orphanet_210159)
Species of origin	Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell	Male
Age at sampling	60Y
Category	Cancer cell line
Publications	PubMed=20461085; DOI=10.1038/sj.bjc.6605689 Wang T., Hu H.-S., Feng Y.-X., Shi J., Li N., Guo W.-X., Xue J., Xie D., Liu S.-R., Wu M.-C., Cheng S.-Q. Characterisation of a novel cell line (CSQT-2) with high metastatic activity derived from portal vein tumour thrombus of hepatocellular carcinoma. Br. J. Cancer 102:1618-1626(2010) Patent=CN101955914B Wu M.-C., Wang T., Cheng J.-Y., Cheng S.-Q., Hu H.-S., Xie D. Human hepatocellular carcinoma cell line with portal vein transfer potential. Patent number CN101955914B, 23-May-2012
Cell line databases/resources	CCRID; 4201PAT-CCTCC00280
Encyclopedic resources	Wikidata; Q54814674
Entry history
Entry creation	06-May-2013
Last entry update	29-Jun-2023
Version number	12